STOCK TITAN

Health In Tech CFO gets 200K-share $1B milestone award

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Health In Tech, Inc. (HIT) CFO and director LinLin Qian reported seven direct stock awards dated November 10, 2026. A 650,000-share Class A restricted award was issued upon stockholder approval of a Plan amendment and vests in 12 equal monthly installments beginning November 15, subject to continued service. Another 800,000 Class A shares vest upon an acquisition closing on or before December 31, 2028, subject to continued service, or are forfeited without consideration.

Separate 600,000-share Class A awards require market capitalization, measured by 10-day VWAP, to exceed $150 million by April 30, 2028, or $300 million by December 31, 2028; each then vests in 12 monthly installments, subject to service. Two further Class A awards of 200,000 shares each have $500 million and $1 billion market-capitalization thresholds due by December 31, 2029, and December 31, 2031, respectively. A 200,000-share Class B award follows the $150 million condition. After the Class A award, the reported holdings included 3,828,516 restricted and 8,138,635 unrestricted Class A shares; Class B holdings were 2,900,000 shares. All unvested restricted shares reported vest in full upon a Change in Control.

Insider Qian LinLin
Role Chief Financial Officer
Type Security Shares Price Value
Grant/Award Class A Common Stock F1 650,000 $0.00 $0.00
Grant/Award Class A Common Stock F2 800,000 $0.00 $0.00
Grant/Award Class A Common Stock F3 600,000 $0.00 $0.00
Grant/Award Class A Common Stock F4 600,000 $0.00 $0.00
Grant/Award Class A Common Stock F5 200,000 $0.00 $0.00
Grant/Award Class A Common Stock F6, F8 200,000 $0.00 $0.00
Grant/Award Class B Common Stock F7, F9 200,000 $0.00 $0.00
Holdings After Transaction: Class A Common Stock — 11,967,151 shares (Direct); Class B Common Stock — 2,900,000 shares (Direct)
Holdings Before and After: Class A Common Stock, 8,917,151 to 11,967,151 shares (Direct); Class B Common Stock, 2,700,000 to 2,900,000 shares (Direct)
Footnotes (9)
  1. F1. Represents restricted shares of Class A Common Stock granted under the Health In Tech, Inc. Equity Incentive Plan (the "Plan") pursuant to a Restricted Stock Award Agreement dated as of October 20, 2026. The grant was contingent upon, and the shares were issued upon, stockholder approval of an amendment to the Plan at the Issuer's 2026 Annual Meeting of Stockholders on November 10, 2026. The shares vest in twelve equal monthly installments commencing November 15, 2026, subject to continued service through each vesting date.
  2. F2. Represents restricted shares of Class A Common Stock that vest in full upon the closing of an acquisition by the Issuer on or before December 31, 2028, subject to continued service through such closing, and are otherwise forfeited without consideration.
  3. F3. Represents restricted shares of Class A Common Stock that are forfeited without consideration unless the Issuer's market capitalization (measured by 10-day VWAP) exceeds $150 million on or before April 30, 2028 (the "Achievement Date"). Thereafter, the shares vest in twelve equal monthly installments, subject to continued service, commencing on the 15th of the month if the Achievement Date is before the 15th, or otherwise on the 1st of the next month.
  4. F4. Represents restricted shares of Class A Common Stock that are forfeited without consideration unless the Issuer's market capitalization (measured by 10-day VWAP) exceeds $300 million on or before December 31, 2028 (the "Achievement Date"). Thereafter, the shares vest in twelve equal monthly installments, subject to continued service, commencing on the 15th of the month if the Achievement Date is before the 15th, or otherwise on the 1st of the next month.
  5. F5. Represents restricted shares of Class A Common Stock that are forfeited without consideration unless the Issuer's market capitalization (measured by 10-day VWAP) exceeds $500 million on or before December 31, 2029 (the "Achievement Date"). Thereafter, the shares vest in twelve equal monthly installments, subject to continued service, commencing on the 15th of the month if the Achievement Date is before the 15th, or otherwise on the 1st of the next month.
  6. F6. Represents restricted shares of Class A Common Stock that are forfeited without consideration unless the Issuer's market capitalization (measured by 10-day VWAP) exceeds $1 billion on or before December 31, 2031 (the "Achievement Date"). Thereafter, the shares vest in twelve equal monthly installments, subject to continued service, commencing on the 15th of the month if the Achievement Date is before the 15th, or otherwise on the 1st of the next month.
  7. F7. Represents restricted shares of Class B Common Stock on the terms described in footnote (3).
  8. F8. Includes 3,828,516 restricted shares of Class A Common Stock and 8,138,635 unrestricted shares of Class A Common Stock. Excludes 200,000 restricted shares of Class B Common Stock, 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.
  9. F9. All unvested restricted shares reported herein vest in full upon a Change in Control (as defined in the Plan).
Class A restricted award issued after Plan approval 650,000 shares Dated November 10, 2026; vests in 12 equal monthly installments beginning November 15, subject to continued service.
Class A acquisition-contingent award 800,000 shares Vests upon an acquisition closing on or before December 31, 2028, subject to continued service.
Class A market-capitalization awards 600,000 shares each Two awards, with market-capitalization thresholds of $150 million and $300 million.
Class A market-capitalization award 200,000 shares Threshold of $500 million by December 31, 2029.
Class A market-capitalization award 200,000 shares Threshold of $1 billion by December 31, 2031.
Class B award 200,000 shares Follows the $150 million market-capitalization condition.
Class A holdings reported after award 3,828,516 restricted shares; 8,138,635 unrestricted shares Reported in the footnote to the Class A award.
Class B holdings after award 2,900,000 shares Reported after the 200,000-share Class B award.
restricted shares financial
"Represents restricted shares of Class A Common Stock"
Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.
Equity Incentive Plan financial
"granted under the Health In Tech, Inc. Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
10-day VWAP financial
"market capitalization (measured by 10-day VWAP)"
10-day VWAP is the average price at which a stock traded over the past ten trading days, weighted by the number of shares exchanged at each price so bigger trades count more. Investors use it like a benchmark or reference line—similar to checking the average speed on a ten-day trip weighted by how long you traveled at each speed—to judge whether current prices are fair, to time trades, and to spot short-term trends or unusual activity.
Change in Control technical
"vest in full upon a Change in Control"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
vesting financial
"vest in twelve equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock awards did HIT CFO LinLin Qian report?

LinLin Qian reported seven direct awards on November 10, 2026: Class A awards of 650,000, 800,000, 600,000, 600,000, 200,000 and 200,000 shares, plus a 200,000-share Class B award. The awards have service, acquisition or market-capitalization conditions, with milestones extending through December 31, 2031.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Qian LinLin

(Last)(First)(Middle)
701 S. COLORADO AVE, SUITE 1

(Street)
STUART FLORIDA 34994

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Health In Tech, Inc. [ HIT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock11/10/2026A650,000(1)A$09,567,151D
Class A Common Stock11/10/2026A800,000(2)A$010,367,151D
Class A Common Stock11/10/2026A600,000(3)A$010,967,151D
Class A Common Stock11/10/2026A600,000(4)A$011,567,151D
Class A Common Stock11/10/2026A200,000(5)A$011,767,151D
Class A Common Stock11/10/2026A200,000(6)A$011,967,151(8)D
Class B Common Stock11/10/2026A200,000(7)A$02,900,000(9)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents restricted shares of Class A Common Stock granted under the Health In Tech, Inc. Equity Incentive Plan (the "Plan") pursuant to a Restricted Stock Award Agreement dated as of October 20, 2026. The grant was contingent upon, and the shares were issued upon, stockholder approval of an amendment to the Plan at the Issuer's 2026 Annual Meeting of Stockholders on November 10, 2026. The shares vest in twelve equal monthly installments commencing November 15, 2026, subject to continued service through each vesting date.
2. Represents restricted shares of Class A Common Stock that vest in full upon the closing of an acquisition by the Issuer on or before December 31, 2028, subject to continued service through such closing, and are otherwise forfeited without consideration.
3. Represents restricted shares of Class A Common Stock that are forfeited without consideration unless the Issuer's market capitalization (measured by 10-day VWAP) exceeds $150 million on or before April 30, 2028 (the "Achievement Date"). Thereafter, the shares vest in twelve equal monthly installments, subject to continued service, commencing on the 15th of the month if the Achievement Date is before the 15th, or otherwise on the 1st of the next month.
4. Represents restricted shares of Class A Common Stock that are forfeited without consideration unless the Issuer's market capitalization (measured by 10-day VWAP) exceeds $300 million on or before December 31, 2028 (the "Achievement Date"). Thereafter, the shares vest in twelve equal monthly installments, subject to continued service, commencing on the 15th of the month if the Achievement Date is before the 15th, or otherwise on the 1st of the next month.
5. Represents restricted shares of Class A Common Stock that are forfeited without consideration unless the Issuer's market capitalization (measured by 10-day VWAP) exceeds $500 million on or before December 31, 2029 (the "Achievement Date"). Thereafter, the shares vest in twelve equal monthly installments, subject to continued service, commencing on the 15th of the month if the Achievement Date is before the 15th, or otherwise on the 1st of the next month.
6. Represents restricted shares of Class A Common Stock that are forfeited without consideration unless the Issuer's market capitalization (measured by 10-day VWAP) exceeds $1 billion on or before December 31, 2031 (the "Achievement Date"). Thereafter, the shares vest in twelve equal monthly installments, subject to continued service, commencing on the 15th of the month if the Achievement Date is before the 15th, or otherwise on the 1st of the next month.
7. Represents restricted shares of Class B Common Stock on the terms described in footnote (3).
8. Includes 3,828,516 restricted shares of Class A Common Stock and 8,138,635 unrestricted shares of Class A Common Stock. Excludes 200,000 restricted shares of Class B Common Stock, 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.
9. All unvested restricted shares reported herein vest in full upon a Change in Control (as defined in the Plan).
/s/ Lori Babcock, as attorney-in-fact for LinLin Qian11/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading